This article was originally published on TipRanks.com Biopharmaceutical company Dynavax Technologies Corporation (NASDAQ:DVAX) recently revealed that Biological E, an Indian biotechnology and biopharmaceutical company, has …
Dynavax Technologies Corporation (DVAX), a biopharmaceutical company, has inked a deal with the U.S.
Dynavax Technologies reported positive results in 153 adults aged 18 years to 55 years for Part A of the Phase-1 clinical trial of …
Shares of Dynavax Technologies Corp. rose about 6% on Feb.
It’s a mixed bag when it comes to opinions on penny stocks. These tickers trading for less than $5 per share divide Wall …
Medigen Vaccine Biologics (MVC) and Dynavax Technologies (DVAX) have announced that MVC has obtained a Taiwan government subsidy for successfully initiating a Phase 1 clinical trial …
Vaccine-focused biopharma Dynavax Technologies (DVAX) has announced a collaboration to develop a universal influenza (flu) vaccine with the Icahn School of Medicine at Mount Sinai. Mount …
Dynavax Technologies (DVAX) is surging 40% in Tuesday’s pre-market trading after revealing that it expects one or more of its collaboration partners will commence …
On your mark, get set, go! The race is on to find an effective vaccine against COVID-19, the novel coronavirus that has spread to 471,000 …
2019 has not been a great year to own biotech stocks (so far). Since the year began, the Nasdaq Biotechnology Index (NBI) is …
